| P50 | author | Andrew L Feldman | Q42397592 |
| P2093 | author name string | Sajjad Hussain | |
| | Tibor Bedekovics | |
| | Paul J Galardy | |
| P2860 | cites work | Transcriptional analysis of the B cell germinal center reaction | Q24554209 |
| | Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma | Q24613755 |
| | The de-ubiquitinase UCH-L1 is an oncogene that drives the development of lymphoma in vivo by deregulating PHLPP1 and Akt signaling | Q24629152 |
| | Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling | Q27860529 |
| | Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: a study by the Groupe d'Etude des Lymphomes de l'Adulte | Q28248195 |
| | The neuron-specific protein PGP 9.5 is a ubiquitin carboxyl-terminal hydrolase | Q28941761 |
| | The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity | Q29547693 |
| | Reverse engineering of regulatory networks in human B cells | Q30004211 |
| | Integrated biochemical and computational approach identifies BCL6 direct target genes controlling multiple pathways in normal germinal center B cells. | Q33634465 |
| | The cell-cycle regulator c-Myc is essential for the formation and maintenance of germinal centers | Q34044132 |
| | Loss of signalling via Gα13 in germinal centre B-cell-derived lymphoma | Q34714068 |
| | Prognosis of patients with diffuse large B cell lymphoma not reaching complete response or relapsing after frontline chemotherapy or immunochemotherapy | Q35218039 |
| | Results of a randomized international study of high-risk central nervous system B non-Hodgkin lymphoma and B acute lymphoblastic leukemia in children and adolescents | Q35750976 |
| | Magnetic-based purification of untouched mouse germinal center B cells for ex vivo manipulation and biochemical analysis | Q35888947 |
| | Molecular distinctions between pediatric and adult mature B-cell non-Hodgkin lymphomas identified through genomic profiling | Q35909668 |
| | Synergy between PI3K signaling and MYC in Burkitt lymphomagenesis | Q36204234 |
| | Identification of human germinal center light and dark zone cells and their relationship to human B-cell lymphomas | Q36249443 |
| | Activity-based ubiquitin-specific protease (USP) profiling of virus-infected and malignant human cells | Q36601348 |
| | Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics | Q36721503 |
| | Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large B-cell lymphoma: a report from the International DLBCL Rituximab-CHOP Con | Q36799606 |
| | PTEN loss defines a PI3K/AKT pathway-dependent germinal center subtype of diffuse large B-cell lymphoma | Q37049376 |
| | Pediatric diffuse large B-cell lymphoma demonstrates a high proliferation index, frequent c-Myc protein expression, and a high incidence of germinal center subtype: Report of the French-American-British (FAB) international study group | Q37265785 |
| | A study of rituximab and ifosfamide, carboplatin, and etoposide chemotherapy in children with recurrent/refractory B-cell (CD20+) non-Hodgkin lymphoma and mature B-cell acute lymphoblastic leukemia: a report from the Children's Oncology Group | Q37310514 |
| | Double-hit B-cell lymphomas | Q37813897 |
| | Relapsed/refractory diffuse large B-cell lymphoma | Q37967335 |
| | Targeting deubiquitinase activity with a novel small-molecule inhibitor as therapy for B-cell malignancies | Q38894421 |
| | Ubiquitin hydrolase UCH-L1 destabilizes mTOR complex 1 by antagonizing DDB1-CUL4-mediated ubiquitination of raptor | Q39214595 |
| | PU.1-dependent regulation of UCH L1 expression in B-lymphoma cells | Q39556264 |
| | Deubiquitinase inhibition by small-molecule WP1130 triggers aggresome formation and tumor cell apoptosis. | Q39636568 |
| | Rapid methods for the analysis of immunoglobulin gene hypermutation: application to transgenic and gene targeted mice | Q39720046 |
| | Role of phosphatidylinositol 3'-kinase/AKT pathway in diffuse large B-cell lymphoma survival | Q40237290 |
| | BCL6 interacts with the transcription factor Miz-1 to suppress the cyclin-dependent kinase inhibitor p21 and cell cycle arrest in germinal center B cells | Q40377462 |
| | PI3 kinase signals BCR-dependent mature B cell survival | Q41886641 |
| | AID-dependent activation of a MYC transgene induces multiple myeloma in a conditional mouse model of post-germinal center malignancies. | Q43059808 |
| | The proto-oncogene MYC is required for selection in the germinal center and cyclic reentry | Q43091743 |
| | High immunohistochemical expression of p-AKT predicts inferior survival in patients with diffuse large B-cell lymphoma treated with immunochemotherapy | Q43143099 |
| | Diffuse large B-cell lymphoma in pediatric patients belongs predominantly to the germinal-center type B-cell lymphomas: a clinicopathologic analysis of cases included in the German BFM (Berlin-Frankfurt-Munster) Multicenter Trial | Q45158002 |
| | A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling. | Q51940347 |
| | Polycomb protein EZH2 expression in diffuse large B-cell lymphoma is associated with better prognosis in patients treated with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone. | Q53080173 |
| | Deregulated BCL6 expression recapitulates the pathogenesis of human diffuse large B cell lymphomas in mice | Q81747975 |
| | Patient age at diagnosis is associated with the molecular characteristics of diffuse large B-cell lymphoma | Q83215929 |
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1564-1574 | |
| P577 | publication date | 2015-12-23 | |
| P1433 | published in | Blood | Q885070 |
| P1476 | title | UCH-L1 is induced in germinal center B cells and identifies patients with aggressive germinal center diffuse large B-cell lymphoma | |
| P478 | volume | 127 | |